Who Supplies Atorvastatin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Atorvastatin exports, with 477+ registered manufacturers shipping to buyers across 145+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 24.3% (export value: $262.9M). Close behind, PIRAMAL PHARMA LIMITED (20.8%, $225.3M). MYLAN LABORATORIES LIMITED (13.6%, $146.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Atorvastatin? Top Manufacturers & Their Buyers
Flow of Atorvastatin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Atorvastatin Supplier Network — Key Market Intelligence
The Atorvastatin export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 24.3% share, shipping $262.9M worth of product across 328 shipments. The second-largest exporter, PIRAMAL PHARMA LIMITED, contributes $225.3M (20.8%) to the overall market. Combined, the top two suppliers alone account for 45.2% of all Atorvastatin exports, indicating a relatively concentrated supply base.
Across all 477 tracked manufacturers, the total Atorvastatin export value stands at $1.1B from 15.0K shipments. The market average shipment value is $72.0K. The single largest buyer relationship in terms of trade value is APOTEX CORP, receiving $225.3M worth of product.
The combined buyer network spans 14 named purchasing companies, including BIOMEDPHARMA, ACCORD HEALTHCARE INC., APOTEX CORP, MYLAN PHARMACEUTICALS INC, XXlanXXrelXXd LXXite and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the first-largest Atorvastatin exporter from India, with a market share of 24.3% and a total export value of $262.9M across 328 shipments. Their average shipment value of $801.6K is above the market average of $72.0K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. BIOMEDPHARMA is the dominant customer, accounting for 73.8% of this supplier's tracked business. Top customers include:
• BIOMEDPHARMA — $194.1M across 242 shipments (73.8% of this supplier's total exports)
• ACCORD HEALTHCARE INC. — $57.6M across 72 shipments (21.9% of this supplier's total exports)
• ACCORD HEALTHCARE INC. — $9.7M across 12 shipments (3.7% of this supplier's total exports)
• ACCORD HEALTHCARE INC. — $1.2M across 2 shipments (0.5% of this supplier's total exports)
• TO THE ORDER — $345.8K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $801.6K is 1013% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.
2PIRAMAL PHARMA LIMITED
PIRAMAL PHARMA LIMITED is the second-largest Atorvastatin exporter from India, with a market share of 20.8% and a total export value of $225.3M across 429 shipments. Their average shipment value of $525.1K is above the market average of $72.0K, suggesting premium or bulk contract pricing.
PIRAMAL PHARMA LIMITED serves 1 named buyer in our database. APOTEX CORP is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• APOTEX CORP — $225.3M across 429 shipments (100.0% of this supplier's total exports)
Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $525.1K is 629% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.
3MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the third-largest Atorvastatin exporter from India, with a market share of 13.6% and a total export value of $146.6M across 330 shipments. Their average shipment value of $444.2K is above the market average of $72.0K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC is the dominant customer, accounting for 89.5% of this supplier's tracked business. Top customers include:
• MYLAN PHARMACEUTICALS INC — $131.2M across 295 shipments (89.5% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $11.0M across 25 shipments (7.5% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $1.7M across 4 shipments (1.2% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $1.4M across 3 shipments (1.0% of this supplier's total exports)
• XXlanXXrelXXd LXXite — $1.3M across 3 shipments (0.9% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $444.2K is 517% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.
4MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the fourth-largest Atorvastatin exporter from India, with a market share of 5.0% and a total export value of $53.7M across 3.2K shipments. Their average shipment value of $16.6K is below the market average of $72.0K, reflecting a high-volume, competitive pricing strategy.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $19.6M across 1.2K shipments (36.5% of this supplier's total exports)
• NOVADOZ PHARMACEUTICALS LLC — $16.7M across 1.0K shipments (31.1% of this supplier's total exports)
• MSN LABORATORIES EUROPE LIMITED., — $9.5M across 568 shipments (17.6% of this supplier's total exports)
• MSN LABORATORIES EUROPE LIMITED., — $5.3M across 319 shipments (9.9% of this supplier's total exports)
• TO THE ORDER — $2.6M across 159 shipments (4.9% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (3.2K shipments) at a per-shipment value of $16.6K, indicating a broad distribution network with many smaller, regular orders.
5UMEDICA LABORATORIES PRIVATE LIMITED
UMEDICA LABORATORIES PRIVATE LIMITED is the fifth-largest Atorvastatin exporter from India, with a market share of 3.4% and a total export value of $37.2M across 235 shipments. Their average shipment value of $158.4K is above the market average of $72.0K, suggesting premium or bulk contract pricing.
UMEDICA LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. LIFESCIENCE LOGISTICS is the dominant customer, accounting for 93.7% of this supplier's tracked business. Top customers include:
• LIFESCIENCE LOGISTICS — $34.9M across 220 shipments (93.7% of this supplier's total exports)
• CRESCENT PHARMA LTD — $927.9K across 6 shipments (2.5% of this supplier's total exports)
• CRESCENT PHARMA LIMI — $656.5K across 4 shipments (1.8% of this supplier's total exports)
• CRESCENT PHARMA LTD — $625.9K across 4 shipments (1.7% of this supplier's total exports)
• Life Science Logisti — $151.8K across 1 shipments (0.4% of this supplier's total exports)
Key Insight: UMEDICA LABORATORIES PRIVATE LIMITED's per-shipment value of $158.4K is 120% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.
6ALKEM LABORATORIES LIMITED
ALKEM LABORATORIES LIMITED is the fifth-largest Atorvastatin exporter from India, with a market share of 3.3% and a total export value of $35.6M across 277 shipments. Their average shipment value of $128.6K is above the market average of $72.0K, suggesting premium or bulk contract pricing.
ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. ASCEND LABOATORIES,LLC C/O UPS is the dominant customer, accounting for 78.5% of this supplier's tracked business. Top customers include:
• ASCEND LABOATORIES,LLC C/O UPS — $28.0M across 217 shipments (78.5% of this supplier's total exports)
• ASCEND LABORATORIES, — $3.3M across 26 shipments (9.3% of this supplier's total exports)
• ASCEND LABORATORIES, — $2.9M across 23 shipments (8.1% of this supplier's total exports)
• ASCEND LABORATORIES — $739.1K across 6 shipments (2.1% of this supplier's total exports)
• ASCEND LABORATORIES, — $702.8K across 5 shipments (2.0% of this supplier's total exports)
Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $128.6K is 79% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Atorvastatin Flows
Once Atorvastatin leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and PIRAMAL PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $1.1B. United States absorbs the largest share at 52.5% ($567.7M), followed by Canada (25.9%) and Malta (3.0%).
In United States — the top destination — named importers include APOTEX CORP, MYLAN PHARMACEUTICALS INC,, LIFESCIENCE LOGISTICS. In Canada, key buyers are BIOMEDPHARMA, ACCORD HEALTHCARE INC.,, ACCORD HEALTHCARE INC..
This geographic spread reflects Atorvastatin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Atorvastatin Go? Top Importing Countries & Their Buyers
Trade flow of Atorvastatin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Atorvastatin imports from India, with a total trade value of $567.7M across 1,877 shipments — representing a 52.5% share of all Atorvastatin exports. The average shipment value of $302.4K is above the global average of $72.0K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Atorvastatin importers in United States: APOTEX CORP is the largest buyer, accounting for 42.6% ($241.6M) of this market's total imports.
• APOTEX CORP — $241.6M (42.6% of United States's total)
• MYLAN PHARMACEUTICALS INC, — $136.0M (24.0% of United States's total)
• LIFESCIENCE LOGISTICS — $36.4M (6.4% of United States's total)
Key Insight: United States's per-shipment average of $302.4K (320% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Atorvastatin imports from India.
2Canada
Canada ranks as the second-largest destination for Atorvastatin imports from India, with a total trade value of $279.4M across 141 shipments — representing a 25.9% share of all Atorvastatin exports. The average shipment value of $2.0M is above the global average of $72.0K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Atorvastatin importers in Canada: BIOMEDPHARMA is the largest buyer, accounting for 69.5% ($194.2M) of this market's total imports.
• BIOMEDPHARMA — $194.2M (69.5% of Canada's total)
• ACCORD HEALTHCARE INC., — $57.6M (20.6% of Canada's total)
• ACCORD HEALTHCARE INC. — $9.9M (3.6% of Canada's total)
Key Insight: Canada's per-shipment average of $2.0M (2651% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Atorvastatin imports from India.
3Malta
Malta ranks as the third-largest destination for Atorvastatin imports from India, with a total trade value of $32.5M across 517 shipments — representing a 3.0% share of all Atorvastatin exports. The average shipment value of $62.8K is below the global average of $72.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Atorvastatin importers in Malta: APL SWIFT SERVICES (MALTA) LTD., is the largest buyer, accounting for 84.9% ($27.6M) of this market's total imports.
• APL SWIFT SERVICES (MALTA) LTD., — $27.6M (84.9% of Malta's total)
Key Insight: Malta receives frequent, smaller shipments of Atorvastatin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Malta is a key market for Atorvastatin imports from India.
4United Kingdom
United Kingdom ranks as the fourth-largest destination for Atorvastatin imports from India, with a total trade value of $30.2M across 446 shipments — representing a 2.8% share of all Atorvastatin exports. The average shipment value of $67.7K is below the global average of $72.0K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Atorvastatin importers in United Kingdom: MSN LABORATORIES EUROPE LIMITED is the largest buyer, accounting for 31.3% ($9.5M) of this market's total imports.
• MSN LABORATORIES EUROPE LIMITED — $9.5M (31.3% of United Kingdom's total)
• MSN LABORATORIES EUROPE LIMITED., — $5.3M (17.6% of United Kingdom's total)
Key Insight: United Kingdom receives frequent, smaller shipments of Atorvastatin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
United Kingdom is a key market for Atorvastatin imports from India.
5Japan
Japan ranks as the fifth-largest destination for Atorvastatin imports from India, with a total trade value of $26.8M across 48 shipments — representing a 2.5% share of all Atorvastatin exports. The average shipment value of $557.6K is above the global average of $72.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Atorvastatin importers in Japan: SAWAI PHARMACEUTICAL CO.LTD. is the largest buyer, accounting for 24.4% ($6.5M) of this market's total imports.
• SAWAI PHARMACEUTICAL CO.LTD. — $6.5M (24.4% of Japan's total)
Key Insight: Japan's per-shipment average of $557.6K (674% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Japan is a key market for Atorvastatin imports from India.
People Also Ask — Atorvastatin Supplier & Trade Network
Who are the top suppliers of Atorvastatin from India?+
Which companies buy Atorvastatin from Indian manufacturers?+
Where does Atorvastatin exported from India go?+
What is the market share of the top Atorvastatin supplier from India?+
What is the average shipment value for Atorvastatin exports from India?+
Is Atorvastatin manufactured in India and exported globally?+
Which country imports the most Atorvastatin from India?+
Who are the buyers of Atorvastatin in Canada?+
How concentrated is the Atorvastatin supplier market in India?+
How do I find verified buyers for Atorvastatin in specific countries?+
Atorvastatin Trade Network — Key Takeaways
- 1INTAS PHARMACEUTICALS LIMITED is India's dominant Atorvastatin exporter with a 24.3% market share and $262.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 477 suppliers collectively account for 70.5% of all tracked Atorvastatin exports, with a combined trade value of $1.1B.
- 3United States is the largest destination market, absorbing 52.5% of India's Atorvastatin exports ($567.7M). Canada (25.9%) and Malta (3.0%) follow.
- 4With 15.0K total shipments averaging $72.0K each, the Atorvastatin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BIOMEDPHARMA, ACCORD HEALTHCARE INC., APOTEX CORP, MYLAN PHARMACEUTICALS INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 145 countries
Network value: $1.1B
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Atorvastatin.
- 2.Flow Mapping: 477 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 15,000 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 145 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
477 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists